Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
CLOPIDOGREL ARENA 75 mg
Antiplatelet agent indicated in the prevention of cardiovascular events (myocardial infarction, stroke)
Active Substance (INN)
CLOPIDOGRELUM
Packaging
1,2,4,12 bl x 7 tabs; 1,3,9,10 bl x 10 tabs
Adverse Reaction Reporting
To report an adverse reaction, please contact us using the email address below and provide all relevant information.
informatii.medicale@arenagroup.roRead the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.